% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Hardy:910107,
author = {Hardy, Aël and Kever, Larissa and Frunzke, Julia},
title = {{A}ntiphage small molecules produced by bacteria – beyond
protein-mediated defenses},
journal = {Trends in microbiology},
volume = {31},
number = {1},
issn = {0966-842X},
address = {Amsterdam [u.a.]},
publisher = {Elsevier Science},
reportid = {FZJ-2022-03615},
pages = {92-106},
year = {2023},
note = {Biotechnologie 1},
abstract = {Bacterial populations face the constant threat of viral
predation exerted by bacteriophages (‘phages’). In
response, bacteria have evolved a wide range of defense
mechanisms against phage challenges. Yet the vast majority
of antiphage defense systems described until now are
mediated by proteins or RNA complexes acting at the
single-cell level. Here, we review small molecule-based
defense strategies against phage infection, with a focus on
the antiphage molecules described recently. Importantly,
inhibition of phage infection by excreted small molecules
has the potential to protect entire bacterial communities,
highlighting the ecological significance of these antiphage
strategies. Considering the immense repertoire of bacterial
metabolites, we envision that the list of antiphage small
molecules will be further expanded in the future.},
cin = {IBG-1},
ddc = {570},
cid = {I:(DE-Juel1)IBG-1-20101118},
pnm = {2171 - Biological and environmental resources for
sustainable use (POF4-217) / DFG project 464434020 -
Inhibierung der Phageninfektion durch aktinobakterielle
Sekundärmetabolite (464434020)},
pid = {G:(DE-HGF)POF4-2171 / G:(GEPRIS)464434020},
typ = {PUB:(DE-HGF)16},
pubmed = {36038409},
UT = {WOS:000912531000001},
doi = {10.1016/j.tim.2022.08.001},
url = {https://juser.fz-juelich.de/record/910107},
}